Cargando…

DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease

Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Persyn, Elodie, Karakachoff, Matilde, Le Scouarnec, Solena, Le Clézio, Camille, Campion, Dominique, Consortium, French Exome, Schott, Jean-Jacques, Redon, Richard, Bellanger, Lise, Dina, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524342/
https://www.ncbi.nlm.nih.gov/pubmed/28742119
http://dx.doi.org/10.1371/journal.pone.0179364
_version_ 1783252450242723840
author Persyn, Elodie
Karakachoff, Matilde
Le Scouarnec, Solena
Le Clézio, Camille
Campion, Dominique
Consortium, French Exome
Schott, Jean-Jacques
Redon, Richard
Bellanger, Lise
Dina, Christian
author_facet Persyn, Elodie
Karakachoff, Matilde
Le Scouarnec, Solena
Le Clézio, Camille
Campion, Dominique
Consortium, French Exome
Schott, Jean-Jacques
Redon, Richard
Bellanger, Lise
Dina, Christian
author_sort Persyn, Elodie
collection PubMed
description Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Association studies of these rare variations show new challenges in terms of statistical analysis. Due to their low frequency, rare variants must be tested by groups. This approach is then hindered by the fact that an unknown proportion of the variants could be neutral. The risk level of a rare variation may be determined by its impact but also by its position in the protein sequence. More generally, the molecular mechanisms underlying the disease architecture may involve specific protein domains or inter-genic regulatory regions. While a large variety of methods are optimizing functionality weights for each single marker, few evaluate variant position differences between cases and controls. Here, we propose a test called DoEstRare, which aims to simultaneously detect clusters of disease risk variants and global allele frequency differences in genomic regions. This test estimates, for cases and controls, variant position densities in the genetic region by a kernel method, weighted by a function of allele frequencies. We compared DoEstRare with previously published strategies through simulation studies as well as re-analysis of real datasets. Based on simulation under various scenarios, DoEstRare was the sole to consistently show highest performance, in terms of type I error and power both when variants were clustered or not. DoEstRare was also applied to Brugada syndrome and early-onset Alzheimer’s disease data and provided complementary results to other existing tests. DoEstRare, by integrating variant position information, gives new opportunities to explain disease susceptibility. DoEstRare is implemented in a user-friendly R package.
format Online
Article
Text
id pubmed-5524342
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55243422017-08-07 DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease Persyn, Elodie Karakachoff, Matilde Le Scouarnec, Solena Le Clézio, Camille Campion, Dominique Consortium, French Exome Schott, Jean-Jacques Redon, Richard Bellanger, Lise Dina, Christian PLoS One Research Article Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Association studies of these rare variations show new challenges in terms of statistical analysis. Due to their low frequency, rare variants must be tested by groups. This approach is then hindered by the fact that an unknown proportion of the variants could be neutral. The risk level of a rare variation may be determined by its impact but also by its position in the protein sequence. More generally, the molecular mechanisms underlying the disease architecture may involve specific protein domains or inter-genic regulatory regions. While a large variety of methods are optimizing functionality weights for each single marker, few evaluate variant position differences between cases and controls. Here, we propose a test called DoEstRare, which aims to simultaneously detect clusters of disease risk variants and global allele frequency differences in genomic regions. This test estimates, for cases and controls, variant position densities in the genetic region by a kernel method, weighted by a function of allele frequencies. We compared DoEstRare with previously published strategies through simulation studies as well as re-analysis of real datasets. Based on simulation under various scenarios, DoEstRare was the sole to consistently show highest performance, in terms of type I error and power both when variants were clustered or not. DoEstRare was also applied to Brugada syndrome and early-onset Alzheimer’s disease data and provided complementary results to other existing tests. DoEstRare, by integrating variant position information, gives new opportunities to explain disease susceptibility. DoEstRare is implemented in a user-friendly R package. Public Library of Science 2017-07-24 /pmc/articles/PMC5524342/ /pubmed/28742119 http://dx.doi.org/10.1371/journal.pone.0179364 Text en © 2017 Persyn et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Persyn, Elodie
Karakachoff, Matilde
Le Scouarnec, Solena
Le Clézio, Camille
Campion, Dominique
Consortium, French Exome
Schott, Jean-Jacques
Redon, Richard
Bellanger, Lise
Dina, Christian
DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title_full DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title_fullStr DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title_full_unstemmed DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title_short DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
title_sort doestrare: a statistical test to identify local enrichments in rare genomic variants associated with disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524342/
https://www.ncbi.nlm.nih.gov/pubmed/28742119
http://dx.doi.org/10.1371/journal.pone.0179364
work_keys_str_mv AT persynelodie doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT karakachoffmatilde doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT lescouarnecsolena doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT lecleziocamille doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT campiondominique doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT consortiumfrenchexome doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT schottjeanjacques doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT redonrichard doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT bellangerlise doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease
AT dinachristian doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease